Skip to main content
Jonathan Gutman, MD, Oncology, Aurora, CO, University of Colorado Hospital

JonathanAGutmanMD

Oncology Aurora, CO

Hematologic Oncology

Assistant Professor, Medicine, University of Colorado School of Medicine

Overview of Dr. Gutman

Dr. Jonathan Gutman is an oncologist in Aurora, CO and is affiliated with multiple hospitals in the area, including University of Colorado Hospital, UCHealth Memorial Hospital, and UCHealth Poudre Valley Hospital. He received his medical degree from New York University Grossman School of Medicine and has been in practice 15 years. He is one of 125 doctors at University of Colorado Hospital and one of 55 doctors at UCHealth Memorial Hospital who specialize in Oncology. He has more than 70 publications and over 500 citings.

Education & Training

  • University of Washington
    University of WashingtonFellowship, Hematology and Medical Oncology, 2006 - 2008
  • University of Colorado
    University of ColoradoResidency, Internal Medicine, 2002 - 2005
  • New York University School of Medicine
    New York University School of MedicineClass of 2002

Certifications & Licensure

  • CO State Medical License
    CO State Medical License 2004 - 2025
  • WA State Medical License
    WA State Medical License 2006 - 2011
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Venetoclax with Azacitidine Disrupts Energy Metabolism and Targets Leukemia Stem Cells in Patients with Acute Myeloid Leukemia  
    Daniel A Pollyea, Jonathan A Gutman, Enkhtsetseg Purev, Clayton Smith, Nature

Abstracts/Posters

  • No Engraftment Advantage after Single or Double Umbilical Cord Blood Transplant (CBT) with the Addition of a Non-HLA Matched Off-the-Shelf Expanded Cord Blood Unit Com...
    Jonathan A Gutman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Developmental Plasticity of Acute Myeloid Leukemia Mediates Resistance to Venetoclax-Based Therapy
    Jonathan A Gutman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Venetoclax and Azacitidine for Older Newly Diagnosed Patients with Acute Myeloid Leukemia: A Single-Institution Pilot Study Using Measurable Residual Disease to Guide ...
    Jonathan A Gutman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • Outcomes Following Allogeneic Stem Cell Transplantation for AML in First Completion Remission Are Comparable between MRD Negative Patients and MRD Positive Patients Re... 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Tracking of AML-Associated Mutations Via Droplet Digital PCR Is Predictive of Outcomes Post-Transplant 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Cord Blood Outperforms Matched, Unrelated Donor in Bone Marrow Transplant
    Cord Blood Outperforms Matched, Unrelated Donor in Bone Marrow TransplantJuly 26th, 2016
  • Supporting a House Bill That Would Improve Access to Clinical Trials for Everyone
    Supporting a House Bill That Would Improve Access to Clinical Trials for EveryoneFebruary 16th, 2024
  • Here’s What Parents Should Know About Cord Blood Banking
    Here’s What Parents Should Know About Cord Blood BankingJuly 17th, 2024
  • Join now to see all

Hospital Affiliations